Corcept Therapeutics | CORT - Cost Of Sales


Corcept Therapeutics reported $4.06M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Acadia Pharmaceuticals USD 28.32M 3.52M Jun/2026
Alaunos Therapeutics USD 0 18K Sep/2024
ANI Pharmaceuticals USD 119.8M 5.3M Jun/2026
Ardelyx USD 4.81M 6.04M Mar/2026
Aurora Cannabis CAD 8.22M 80.38M Mar/2026
BioMarin Pharmaceutical USD 276.29M 76.8M Jun/2026
Bristol-Myers Squibb USD 7.89B 4.03B Jun/2026
Canopy Growth CAD 62.98M 9.91M Mar/2026
Corcept Therapeutics USD 4.06M 1.18M Jun/2026
Eli Lilly USD 3.27B 309M Jun/2026
J&J USD 8B 67M Jun/2026
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Lexicon Pharmaceuticals USD 201K 191K Dec/2025
Merck USD 3.14B 200M Jun/2026
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Novartis USD 3.71B 251M Jun/2026
Novartis USD 3.46B 83M Mar/2026
Omeros USD 33.16M 18.52M Jun/2024
Pacira USD 58.49M 7.75M Jun/2026
Pfizer USD 4.09B 498M Jun/2026
Supernus Pharmaceuticals USD 59M 9.97M Jun/2026
TG Therapeutics USD 41.19M 7.68M Jun/2026